Jennifer BourniqueAssociate Director, Risk Management & Central Monitoring at The Janssen Pharmaceutical Companies of Johnson & Johnson
Jennifer Bournique is an Associate Director in the Janssen R&D Risk Management & Central Monitoring Group with a focus on Central Statistical Surveillance. Jennifer has been a member of the group in various roles for the more than four years contributing to the implementation of Analytical Risk-Based Monitoring, process improvements as well as oversight of the department metrics. Jennifer has over 20 years of clinical research experience in both Pharma and Device. Prior to joining Janssen R&D, she held a number of roles over 26 years at Roche Diagnostics in both development and clinical trials.